Published in Law and Health Weekly, December 5th, 2009
These trials were the first ever to test a therapy that works at the level of the brain to enhance libido in women reporting low sexual desire, said John M. Thorp, M.D., McAllister distinguished professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill and the principal investigator for North America in the studies.
"Flibanserin was a poor antidepressant," Thorp said. "However, astute observers noted that it increased libido in laboratory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.